Last updated on February 2018

Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)

Brief description of study

The objective of this study is to establish the performance of an assay that detects mRNA transcript levels in patients diagnosed with CML. The study is conducted at locations within the United States. Testing is performed on peripheral blood specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.

Clinical Study Identifier: NCT03421626

Contact Investigators or Research Sites near you

Start Over

Luis Barreras, MD

Broward Oncology Associates
Fort Lauderdale, FL United States
  Connect »

Alan Langerak, MD

St. Alphonsus Regional Medical Center
Boise, ID United States
  Connect »

Mohammed Wallam, MD

WJB Dorn VA Medical Center
Columbia, SC United States
  Connect »

Vivian Oehler, MD

Fred Hutchinson Cancer Research Center
Seattle, WA United States
  Connect »

Salman Osman, MD

United Hospital Center
Bridgeport, WV United States
  Connect »

Arvinder Bir, MD

St. Mary's Medical Center
Huntington, WV United States
  Connect »

Kajal Sitwala, MD

Marshfield Clinic
Marshfield, WI United States
  Connect »